Last $9.60 USD
Change Today +0.15 / 1.59%
Volume 52.0K
OVAS On Other Exchanges
As of 8:10 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

ovascience inc (OVAS) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/9/13 - $14.44
52 Week Low
05/9/14 - $5.51
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for OVASCIENCE INC (OVAS)

Related News

No related news articles were found.

ovascience inc (OVAS) Related Businessweek News

No Related Businessweek News Found

ovascience inc (OVAS) Details

OvaScience, Inc., a life sciences company, is engaged in the discovery, development, and commercialization of new treatments for infertility. The company’s patented technology is based on the discovery of egg precursor cells (EggPCs), which are found in the ovaries. It is developing various fertility treatment options designed to enhance egg quality and in vitro fertilization (IVF) comprising AUGMENT to improve egg quality and increase the success of IVF by transferring mitochondria from a woman's EggPCs to her mature egg during IVF; OvaPrime for boosting a woman's egg reserve by transferring the EggPCs from the outer layer of her ovary back into the ovary prior to IVF; OvaTure to create mature fertilizable eggs from a woman’s own EggPCs without the need for hormone injections; and OvaXon to develop an approach to the prevention of genetic disease and animal health. The company was formerly known as Ovastem, Inc. and changed its name to OvaScience, Inc. in May 2011. OvaScience, Inc. was founded in 2011 and is based in Cambridge, Massachusetts.

28 Employees
Last Reported Date: 02/27/14
Founded in 2011

ovascience inc (OVAS) Top Compensated Officers

Co-Founder, Chief Executive Officer, Presiden...
Total Annual Compensation: --
Principal Financial Officer, Principal Accoun...
Total Annual Compensation: $310.0K
Chief Scientific Officer and Chair of Scienti...
Total Annual Compensation: $106.3K
Compensation as of Fiscal Year 2013.

ovascience inc (OVAS) Key Developments

OvaScience, Inc. Presents at BIO International Convention, Jun-23-2014

OvaScience, Inc. Presents at BIO International Convention, Jun-23-2014 . Venue: San Diego Convention Center, San Diego, California, United States.

Kirby McInerney LLP Announces Class Action Lawsuit on Behalf of OvaScience, Inc

The law firm of Kirby McInerney LLP announced that a class action lawsuit has been commenced in the United States District Court for the District of Connecticut on behalf of investors who acquired OvaScience, Inc. securities from February 25, 2013 through September 10, 2013. By law, investors have until August 5, 2014 to file a motion to be appointed as lead plaintiff in the investor lawsuit.

OvaScience, Inc. Presents at JMP Securities Healthcare Conference, Jun-25-2014 11:30 AM

OvaScience, Inc. Presents at JMP Securities Healthcare Conference, Jun-25-2014 11:30 AM. Venue: The Westin New York Grand Central, 212 East 42nd Street, New York, NY 10017, United States. Speakers: Arthur Tzianabos, Chief Scientific Officer and Chair of Scientific Advisory Board.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OVAS:US $9.60 USD +0.15

OVAS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for OVAS.
View Industry Companies

Industry Analysis


Industry Average

Valuation OVAS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 2.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OVASCIENCE INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at